Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Assist Reprod Genet. 2012 May;29(5):381-90. doi: 10.1007/s10815-012-9727-9. Epub 2012 Mar 14.

Methods for comprehensive chromosome screening of oocytes and embryos: capabilities, limitations, and evidence of validity.

Author information

  • 1Reproductive Medicine Associates of New Jersey, Morristown, NJ 07960, USA. ntreff@rmanj.com

Abstract

Preimplantation aneuploidy screening of cleavage stage embryos using fluorescence in situ hybridization (FISH) may no longer be considered the standard of care in reproductive medicine. Over the last few years, there has been considerable development of novel technologies for comprehensive chromosome screening (CCS) of the human genome. Among the notable methodologies that have been incorporated are whole genome amplification, metaphase and array based comparative genomic hybridization, single nucleotide polymorphism microarrays, and quantitative real-time PCR. As these methods become more integral to treating patients with infertility, it is critical that clinicians and scientists obtain a better understanding of their capabilities and limitations. This article will focus on reviewing these technologies and the evidence of their validity.

PMID:
22415246
[PubMed - indexed for MEDLINE]
PMCID:
PMC3348286
Free PMC Article

Images from this publication.See all images (3)Free text

Fig. 1
Fig. 2
Fig. 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk